Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact
Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: RAP1A

Gene summary for RAP1A

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

RAP1A

Gene ID

5906

Gene nameRAP1A, member of RAS oncogene family
Gene AliasC21KG
Cytomap1p13.2
Gene Typeprotein-coding
GO ID

GO:0000165

UniProtAcc

A8KAH9


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
5906RAP1AHTA11_3410_2000001011HumanColorectumAD1.22e-06-3.99e-010.0155
5906RAP1AHTA11_7696_3000711011HumanColorectumAD1.15e-04-3.24e-010.0674
5906RAP1AHTA11_99999974143_84620HumanColorectumMSS2.21e-05-3.29e-010.3005
5906RAP1AF007HumanColorectumFAP1.27e-03-3.62e-010.1176
5906RAP1AA001-C-207HumanColorectumFAP5.35e-08-3.55e-010.1278
5906RAP1AA015-C-203HumanColorectumFAP1.27e-24-4.54e-01-0.1294
5906RAP1AA015-C-204HumanColorectumFAP3.85e-06-3.12e-01-0.0228
5906RAP1AA014-C-040HumanColorectumFAP5.54e-04-4.30e-01-0.1184
5906RAP1AA002-C-201HumanColorectumFAP1.77e-16-3.99e-010.0324
5906RAP1AA002-C-203HumanColorectumFAP1.36e-03-1.74e-010.2786
5906RAP1AA001-C-119HumanColorectumFAP1.64e-07-4.78e-01-0.1557
5906RAP1AA001-C-108HumanColorectumFAP1.07e-15-3.77e-01-0.0272
5906RAP1AA002-C-205HumanColorectumFAP1.57e-22-4.91e-01-0.1236
5906RAP1AA001-C-104HumanColorectumFAP1.27e-02-2.63e-010.0184
5906RAP1AA015-C-005HumanColorectumFAP2.66e-04-2.22e-01-0.0336
5906RAP1AA015-C-006HumanColorectumFAP3.38e-14-4.89e-01-0.0994
5906RAP1AA015-C-106HumanColorectumFAP1.78e-11-3.22e-01-0.0511
5906RAP1AA002-C-114HumanColorectumFAP5.99e-15-3.90e-01-0.1561
5906RAP1AA015-C-104HumanColorectumFAP1.63e-23-5.01e-01-0.1899
5906RAP1AA001-C-014HumanColorectumFAP2.42e-10-3.48e-010.0135
Page: 1 2 3 4 5 6 7 8 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
Colorectum (GSE201348)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.FAP: Familial adenomatous polyposis
CRC: Colorectal cancer
Colorectum (HTA11)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AD: Adenomas
SER: Sessile serrated lesions
MSI-H: Microsatellite-high colorectal cancer
MSS: Microsatellite stable colorectal cancer
EsophagusThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ESCC: Esophageal squamous cell carcinoma
HGIN: High-grade intraepithelial neoplasias
LGIN: Low-grade intraepithelial neoplasias
LiverThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.HCC: Hepatocellular carcinoma
NAFLD: Non-alcoholic fatty liver disease
Oral CavityThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.EOLP: Erosive Oral lichen planus
LP: leukoplakia
NEOLP: Non-erosive oral lichen planus
OSCC: Oral squamous cell carcinoma
SkinThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AK: Actinic keratosis
cSCC: Cutaneous squamous cell carcinoma
SCCIS:squamous cell carcinoma in situ
ThyroidThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ATC: Anaplastic thyroid cancer
HT: Hashimoto's thyroiditis
PTC: Papillary thyroid cancer
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
GO:00018895ColorectumCRCliver development36/2078147/187233.41e-061.50e-0436
GO:00313464ColorectumCRCpositive regulation of cell projection organization67/2078353/187237.45e-062.72e-0467
GO:00610284ColorectumCRCestablishment of endothelial barrier16/207846/187231.91e-055.68e-0416
GO:00995042ColorectumCRCsynaptic vesicle cycle39/2078181/187233.43e-058.71e-0439
GO:00347642ColorectumCRCpositive regulation of transmembrane transport44/2078219/187236.68e-051.45e-0344
GO:00097435ColorectumCRCresponse to carbohydrate49/2078253/187237.07e-051.51e-0349
GO:00435473ColorectumCRCpositive regulation of GTPase activity49/2078255/187238.67e-051.77e-0349
GO:00458605ColorectumCRCpositive regulation of protein kinase activity67/2078386/187231.34e-042.55e-0367
GO:00336745ColorectumCRCpositive regulation of kinase activity77/2078467/187232.42e-044.00e-0377
GO:00018853ColorectumCRCendothelial cell development17/207864/187234.59e-046.70e-0317
GO:00380931ColorectumCRCFc receptor signaling pathway14/207850/187238.08e-041.02e-0214
GO:00990723ColorectumCRCregulation of postsynaptic membrane neurotransmitter receptor levels16/207862/187239.40e-041.15e-0216
GO:00974214ColorectumCRCliver regeneration11/207835/187231.02e-031.20e-0211
GO:0050804ColorectumCRCmodulation of chemical synaptic transmission70/2078439/187231.15e-031.33e-0270
GO:0099177ColorectumCRCregulation of trans-synaptic signaling70/2078440/187231.23e-031.38e-0270
GO:00230611ColorectumCRCsignal release72/2078463/187231.95e-031.96e-0272
GO:19018883ColorectumCRCregulation of cell junction assembly36/2078204/187233.30e-032.84e-0236
GO:00031584ColorectumCRCendothelium development26/2078136/187233.91e-033.24e-0226
GO:00510513ColorectumCRCnegative regulation of transport71/2078470/187234.33e-033.47e-0271
GO:00713203ColorectumCRCcellular response to cAMP13/207853/187234.42e-033.47e-0213
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
hsa04520ColorectumADAdherens junction50/209293/84651.52e-092.83e-081.81e-0850
hsa04530ColorectumADTight junction76/2092169/84655.49e-099.69e-086.18e-0876
hsa04722ColorectumADNeurotrophin signaling pathway50/2092119/84652.28e-052.24e-041.43e-0450
hsa05417ColorectumADLipid and atherosclerosis73/2092215/84651.31e-038.27e-035.27e-0373
hsa04015ColorectumADRap1 signaling pathway71/2092210/84651.72e-039.68e-036.18e-0371
hsa05211ColorectumADRenal cell carcinoma28/209269/84652.58e-031.37e-028.75e-0328
hsa04510ColorectumADFocal adhesion67/2092203/84654.40e-032.17e-021.38e-0267
hsa04670ColorectumADLeukocyte transendothelial migration41/2092114/84654.60e-032.20e-021.40e-0241
hsa04720ColorectumADLong-term potentiation26/209267/84657.26e-032.97e-021.89e-0226
hsa04972ColorectumADPancreatic secretion36/2092102/84651.06e-023.98e-022.54e-0236
hsa045201ColorectumADAdherens junction50/209293/84651.52e-092.83e-081.81e-0850
hsa045301ColorectumADTight junction76/2092169/84655.49e-099.69e-086.18e-0876
hsa047221ColorectumADNeurotrophin signaling pathway50/2092119/84652.28e-052.24e-041.43e-0450
hsa054171ColorectumADLipid and atherosclerosis73/2092215/84651.31e-038.27e-035.27e-0373
hsa040151ColorectumADRap1 signaling pathway71/2092210/84651.72e-039.68e-036.18e-0371
hsa052111ColorectumADRenal cell carcinoma28/209269/84652.58e-031.37e-028.75e-0328
hsa045101ColorectumADFocal adhesion67/2092203/84654.40e-032.17e-021.38e-0267
hsa046701ColorectumADLeukocyte transendothelial migration41/2092114/84654.60e-032.20e-021.40e-0241
hsa047201ColorectumADLong-term potentiation26/209267/84657.26e-032.97e-021.89e-0226
hsa049721ColorectumADPancreatic secretion36/2092102/84651.06e-023.98e-022.54e-0236
Page: 1 2 3 4 5 6 7 8 9 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
RAP1ASNVMissense_Mutationrs749041743c.367N>Ap.Glu123Lysp.E123KP62834protein_codingdeleterious(0.03)benign(0.072)TCGA-5L-AAT1-01Breastbreast invasive carcinomaFemale<65III/IVHormone TherapyletrozolSD
RAP1ASNVMissense_Mutationnovelc.55N>Gp.Leu19Valp.L19VP62834protein_codingdeleterious(0.03)probably_damaging(0.944)TCGA-BH-A0B6-01Breastbreast invasive carcinomaFemale<65I/IIUnknownUnknownSD
RAP1ASNVMissense_Mutationc.445A>Gp.Lys149Glup.K149EP62834protein_codingdeleterious(0)possibly_damaging(0.727)TCGA-FU-A3HZ-01Cervixcervical & endocervical cancerFemale<65I/IIChemotherapycisplatinCR
RAP1ASNVMissense_Mutationc.25C>Ap.Leu9Ilep.L9IP62834protein_codingdeleterious(0.02)probably_damaging(0.913)TCGA-A6-6781-01Colorectumcolon adenocarcinomaMale<65III/IVChemotherapyoxaliplatinSD
RAP1ASNVMissense_Mutationc.344N>Ap.Gly115Aspp.G115DP62834protein_codingdeleterious(0)probably_damaging(1)TCGA-AA-3672-01Colorectumcolon adenocarcinomaFemale>=65III/IVUnknownUnknownSD
RAP1ASNVMissense_Mutationc.160G>Ap.Glu54Lysp.E54KP62834protein_codingdeleterious(0)benign(0.28)TCGA-AG-A002-01Colorectumrectum adenocarcinomaMale<65I/IIUnknownUnknownSD
RAP1ASNVMissense_Mutationnovelc.247T>Gp.Ser83Alap.S83AP62834protein_codingdeleterious(0.03)probably_damaging(0.972)TCGA-F5-6814-01Colorectumrectum adenocarcinomaMale<65I/IIUnknownUnknownSD
RAP1ASNVMissense_Mutationc.115T>Cp.Ser39Prop.S39PP62834protein_codingdeleterious(0.01)probably_damaging(0.994)TCGA-B5-A11E-01Endometriumuterine corpus endometrioid carcinomaFemale<65I/IIUnknownUnknownSD
RAP1ASNVMissense_Mutationc.344N>Ap.Gly115Aspp.G115DP62834protein_codingdeleterious(0)probably_damaging(1)TCGA-DI-A0WH-01Endometriumuterine corpus endometrioid carcinomaFemale<65I/IIUnknownUnknownSD
RAP1ASNVMissense_Mutationnovelc.470N>Cp.Ile157Thrp.I157TP62834protein_codingdeleterious(0.05)possibly_damaging(0.754)TCGA-E6-A1LX-01Endometriumuterine corpus endometrioid carcinomaFemale<65I/IIUnknownUnknownSD
Page: 1 2 3 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
Page: 1